source
- Regeneron expands partnership with CytomX as other pharma partners exitRegeneron announced it will deepen its collaboration with CytomX Therapeutics, a Bay Area biotech. The decision follows CytomX losing several partnership agreements with other large pharmaceutical…
- Legend Biotech shares jump 40% after promising early CAR-T data in Non-Hodgkin’s lymphomaShares of Legend Biotech rose more than 40% after the company released early results from its in vivo CAR‑T therapy targeting Non‑Hodgkin’s lymphoma. The data showed encouraging activity and a mana…